Most Popular - Shares of Questcor Pharmaceuticals (NASDAQ:QCOR) are under pressure Friday, down 10% in morning trading on news that unknown drug company Cerium Pharmaceuticals has received Orphan … Continue Reading
Read NowLong Ideas - Shares of Endo Pharmaceuticals (NASDAQ:ENDP) are trading at a deep discount to other pharmaceutical companies, with the last dip in price coming on the heels … Continue Reading
Read NowLong Ideas - Merge Healthcare (NASDAQ:MRGE) reported adjusted 3Q 2012 revenues and EPS of $61.0 million and $0.01, compared to Wall St. Consensus expectations of $62.9 million and … Continue Reading
Read NowLong Ideas - While investors have been focusing their attention on palifosfamide and the upcoming phase III data, Ziopharm (NASDAQ:ZIOP) released some initial phase I data of Ad-RTS IL-12 … Continue Reading
Read NowMost Popular - Our earnings preview supposed that in-line QCOR earnings could improve share price. QCOR delivered well-above estimates, but shares remained flat following, as reimbursement concerns still linger. … Continue Reading
Read NowMost Popular - Before noon, shares of Columbia Laboratories (NASDAQ:CBRX) have already exchanged hands at more than ten times average volume, and the stock is down 40%. The … Continue Reading
Read NowMost Popular - Shares of St. Jude Medical (NYSE:STJ) fell Thursday after the company announced negative results from the RESPECT trial, which was expected to support U.S. approval … Continue Reading
Read Now